Objective To report stillbirth and early neonatal mortality and to quantify the relative importance of different primary obstetric causes of perinatal mortality in 171 perinatal deaths from 7993 pregnancies that ended after 28 weeks in nulliparous women. Methods A review of all stillbirths and early newborn deaths reported in the WHO calcium supplementation trial for the prevention of pre-eclampsia conducted at seven WHO collaborating centres in Argentina, Egypt, India, Peru, South Africa and Viet Nam. We used the Baird-Pattinson system to assign primary obstetric causes of death and classified causes of early neonatal death using the International classification of diseases and related health problems, Tenth revision (ICD-10). Findings Stillbirth rate was 12.5 per 1000 births and early neonatal mortality rate was 9.0 per 1000 live births. Spontaneous preterm delivery and hypertensive disorders were the most common obstetric events leading to perinatal deaths (28.7% and 23.6%, respectively). Prematurity was the main cause of early neonatal deaths (62%). Conclusions Advancements in the care of premature infants and prevention of spontaneous preterm labour and hypertensive disorders of pregnancy could lead to a substantial decrease in perinatal mortality in hospital settings in developing countries. Voir page 703 le résumé en français. En la página 704 figura un resumen en español.
Introduction
A two-thirds reduction of mortality in children less than 5 years old by 2015 is one of the UN Millennium Development Goals. 1 Despite a decline in mortality in children in this age group in the last few decades, neonatal mortality numbers have not changed substantially. While infant mortality rates are expected to decrease as a result of the widespread implementation of effective interven--tions such as vaccines and oral rehydra--tion therapy, the proportion of neonatal deaths is likely to increase. .
‫صفحة‬ ‫يف‬ ‫بالعربية‬ ‫امللخص‬ ‫عىل‬ ‫االطالع‬ ‫ميكن‬
area of newborn health. Of the 4 mil--lion neonatal deaths that occur every year, 98% are in the poorest countries of the world. This figure seems even more catastrophic when seen in the light of the estimate that for every neonatal death there is one stillbirth. Perinatal deaths are responsible for about 7% of the total global burden of disease. 2 This percentage exceeds that caused by vaccine-preventable diseases and malaria together. The disparity between highincome and low-income countries in neonatal mortality is unacceptably large and continues to increase. 3 Knowledge of the relative impor--tance of the different causes of stillbirth and neonatal deaths in developing coun--tries is still lacking. 2 Preterm birth, infec--tion and birth asphyxia are thought to be the main causes of death in newborn babies worldwide. 4 However, Kulmala et al. 5 report that the importance of causes of death may vary according to whether the birth setting was a hospital or in the community. 5 In hospital-based surveys, women who are at high risk of negative outcomes (e.g. referred cases) might be over-represented, while community based studies may be less reliable with respect to accurate diagnosis of the causes of deaths. Additionally, surveys -both hospital and community based -may not provide information on pregnancy
Research

Research Stillbirth and neonatal death in developing countries
Nhu Thi Nguyen Ngoc et al.
complications or events prior to delivery that may have influenced the risk of death for the fetus or the newborn child.
From an obstetric and neonatal care perspective, such information is crucial if the primary events that started the pathological process leading to the death of the fetus or the newborn child are to be understood. 6 Here, we report primary obstetric causes of death and rates of early neo--natal death (until 7 days postpartum) and stillbirth (fetal death after 28 weeks' gestation) in 7993 pregnancies of nul--liparous women enrolled in a trial of calcium supplementation for the preven--tion of pre-eclampsia conducted in six developing countries. 7 Additionally, final neonatal causes of death are reported and we assess differences in mortality by centre and gestational age at delivery.
Methods
Study population
Between 2001 and 2004 WHO con--ducted a multicentre, randomized, placebo-controlled, double-blind trial of calcium supplementation for the prevention of pre-eclampsia in women with low calcium intake. 7 Seven centres in six countries participated in the trial: Rosario (Argentina), Assiut (Egypt), Nagpur and Vellore (India), Lima (Peru), East London (South Africa) and Ho Chi Minh City (Viet Nam).
Pregnant women receiving antena--tal care between November 2001 and July 2003 at the participating centres were eligible for the trial if gestational age was less than 20 weeks, they were nulliparous and willing and able to give informed consent. Gestational age at trial entry was established with use of the "best obstetric estimate", including ultrasound examination (if required) by the attending obstetrician. Women were deemed ineligible if they had history of urolithiasis or symptoms suggestive of urolithiasis or any renal disease. Other exclusion criteria were: parathyroid disease; blood pressure >140 mmHg systolic and/or >90 mmHg diastolic; treatment with antihypertensives, diuret--ics, digoxin, phenytoin or tetracyclines; and a history of hypertension. Women who were planning to deliver in a health facility outside the study area were also excluded.
Participants were randomly allo--cated either a supplement of 1500 mg per day of elemental calcium as calcium carbonate or a placebo from the time of enrolment until delivery or initiation of any magnesium sulfate treatment or the clinical suspicion of urolithiasis. After enrolment, women were examined at monthly intervals or more often by study personnel who completed specific data collection forms at each antenatal visit and hospital admission, and at delivery. More details of the study design and results of maternal and neonatal out--comes by supplement type are presented elsewhere.
7
Calculating mortality and stillbirth
Early neonatal mortality and stillbirths were calculated, overall and by gesta--tional age intervals, as the number of early neonatal deaths and stillbirths per 1000 live births and all births, respec--tively. To allow for comparisons to be made between centres and other studies, the numerator and the denominator of all rate calculations included only fetuses and infants of at least 28 weeks' gesta--tion, as indicated by ICD-10.
The risk and cumulative probability of stillbirth and early neonatal mortality (per 1000 births and live births, respec--tively) by gestational age were calculated using Kaplan-Meier survival analysis methods.
Assigning cause of death
One author (MM), who was unaware of treatment allocation, assigned primary causes of deaths on the basis of informa--tion extracted from the data-collection forms completed during pregnancy and during labour and delivery. Only one cause per case was assigned.
Cause of death assignment was made in accordance with a modified version of the classification system proposed by Baird et al. 8 in 1954 to determine primary obstetric causes for fetal and neonatal deaths. Pattinson et al. 6 adapted the system for use in devel--oping country settings allowing for the identification of the following primary obstetrics causes of death: spontaneous preterm labour (<37 weeks), infections, antepartum haemorrhage, intrauterine growth restriction, hypertension, fetal abnormality, trauma and intrapartum asphyxia, maternal disease, other, unex--plained intrauterine death and multiple pregnancy.
Research teams at each centre as--signed final neonatal causes of death us--ing information extracted from hospital records. Causes of death were coded in 
Results
The 7993 pregnancies included in this study were among the 8325 women enrolled in the WHO calcium supple--mentation trial for the prevention of pre-eclampsia. 4151 women were randomly assigned to receive calcium supplementation while 4161 received a placebo. There were 30 multiple pregnancies in the calcium group and 36 in the placebo group. Delivery in--formation was not available for 3.4% and 3.7% of the recruited women in the calcium and placebo group, re--spectively. We recorded 100 stillbirths and 71 early neonatal deaths during the study period. There were 12.5 stillbirths per 1000 births and early neonatal mortal--ity was 9.0 per 1000 live births.
Of the 171 pregnancies that ended with a perinatal death, 107 terminated before term -87 by spontaneous delivery and 30 by indicated preterm delivery. Fig. 1 shows the trends in early neo--natal mortality, stillbirths, early neonatal mortality risk and stillbirth risk over gestational time. While early neonatal mortality and stillbirth rates decreased with advancing gestational age, the risk of stillbirth and early neonatal death remained high throughout gestation. This was expected because the stillbirth risk quantifies the hazard of stillbirth and is calculated by including in the denominator the number of undelivered fetuses, which decreases with gestational time. 9 The most common primary ob-- Table 1 ). The rela--tive importance of these two primary obstetric causes of death is reflected in the causes of 71 early neonatal deaths, 60.5% of which were attributable to prematurity (Table 2 ). An assessment of numbers of death by supplement type showed that hypertensive disorders were less common in the calcium group (P = 0.04) 7 . Table 3 shows the relative im--portance of various causes of death in newborns at different intervals of gestational age at delivery, overall and by supplement type. Prematurity remained the most important cause of death even when gestational ages ap--proached term.
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Discussion
Our analysis indicates that hypertensive disorders and spontaneous preterm de--livery were the main primary obstetric events that led to fetal or newborn deaths in pregnancies included the WHO multinational calcium supplementation trial. 7 Stratified analysis by supplement type showed that calcium supplementa--tion was associated with an important reduction in deaths attributable to hy--pertensive disorders of pregnancy. This observation suggests that simple and affordable interventions such as nutri--tional supplementation might contribute to a decrease in mortality even at second--ary and tertiary care health facilities. 7 The most important causes of early neonatal deaths were prematurity, as--phyxia and congenital anomalies. Pre--maturity was the single most important cause of death in infants born before 37 weeks. This finding is noteworthy since in developed countries, where intensive neonatal care is available, only very pre--term babies are at risk of dying. Prema--turity, however, has devastating effects in developing countries where mortality is high even at late gestational ages.
Although the study was conducted in hospitals that had neonatal intensive care units or where referral to tertiary care was possible, the high numbers of early neonatal deaths and stillbirths that we observed were larger than those re--ported in developed countries. 9, 10 This difference suggests that improvement in health system performance, particularly in the prevention and treatment of ob--stetric and neonatal complications, could lead to important decreases in perinatal mortality in developing countries even in populations with access to secondary and tertiary care facilities.
Although our analysis showed dif--ferences in the relative importance of primary obstetric causes between study sites, results of stratified analysis by centre showed that spontaneous de--livery and/or hypertension tended to persist as the most important causes at all centres. However, these results should be interpreted with caution since sample sizes were small when analysis was done by individual centres. Differ--ences by centre may be attributable to chance but could also reflect variations in the availability of specific forms of care -i.e. corticosteroid use and/or exposure to different diseases, such as syphilis or malaria. However, since our data is derived from the trial datacollection forms rather than from medi--cal records we are not able to speculate on this issue. While the collection of data by standardized procedures in the context of a clinical trial assures the uni--formity and quality of data examined, it inevitably limits the amount of informa--tion available.
We also observed differences be--tween singleton and multiple pregnan--cies with respect to primary causes of death; however, we think the number of multiple pregnancies is too small to allow for a meaningful interpretation of this observation. Interestingly, we noted a re--duced percentage of stillbirths related to infection when compared with data from other published work. 11, 12 This finding might be explained by the fact that we assigned only one cause of death and that in this context hypertensive disorders and preterm delivery might frequently have been rated as the primary diagnosis rather than infection, especially if access to confirmatory laboratory analysis was limited. The design of the clinical trial com--bined the characteristics of community and hospital based studies because women were recruited in general antenatal care clinics before 20 weeks' gestation and were followed up until delivery and hospital discharge, thus avoiding the bias of over-representation of hospital referral cases. In addition, most deliver--ies happened in hospital settings under medical supervision, and medical staff could ascertain causes of death. Our study, therefore, offers a reliable picture of the relative importance of different determinants of stillbirth and newborn mortality in populations of nulliparous pregnant women in several developing countries and could be defined as set in mixed, community and hospital, settings. However, in interpreting the data one must consider that the study population received antenatal care regu--larly and in the context of a research project. Furthermore, the study inclusion criteria targeted women at high risk of pre-eclampsia (those with a low calcium intake and nulliparous). 7, 13 Recruitment to the study before 20 weeks' gestation
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was a requirement to allow for the effect of calcium supplementation. While these features of the study design could limit the external validity of the study, we think the results are informative when applied to populations of women who receive regular antenatal care and who give birth in health facilities.
Compared with other studies con--ducted in community and/or hospital settings, our results could provide an indication on how future trends in stillbirth and neonatal mortality may develop. Global estimates of neonatal mortality published in 2005 show that, worldwide, 27% of deaths in newborns are attributable to prematurity; infec--tion and asphyxia account for about one third of deaths each. 4 Those estimates are consistent with the results of a large community study from Bangladesh re--porting data on almost 4000 deliveries, 14 which have shown that intrapartum conditions and preterm delivery were the most important determinants of perinatal death.
The relative importance of causes of deaths is likely to change when moving from community to hospital settings, as shown by a very large study from South Africa which included data from more than 300 000 deliveries in hospitals and health facilities located in metropolitan, city and rural areas. 15 Results showed that hypertensive disorders were the most important cause of perinatal death, followed by preterm delivery and intra--partum conditions.
Conclusion
The conclusion that can be drawn from the comparisons of the results of these large studies is that preterm delivery and intrapartum-related causes are the maternal complications most likely to contribute to the risk of perinatal death in poor and disadvantaged populations, especially for deliveries occurring out--side hospitals or health-care facilities. However, it is likely that their relative importance will change in the future. Making effective obstetric and newborn care practices widely available and ensuring adequate and timely access to care, especially for disadvantaged populations with no hospital care, could reduce the risk associated with both preterm delivery and intrapartum complications. If these improvements are implemented, it is plausible to ex--pect a reduction in the proportion of perinatal mortality attributed to intra--partum complications and an increase in the relative importance of preterm delivery and hypertensive disorders of pregnancy. This possible scenario is lent support by our results from almost 8000 pregnancies. Therefore, research efforts to identify the causes of preterm delivery and hypertensive disorders of pregnancy should be encouraged. The ultimate objective should be to translate new knowledge into the development of effective screening, preventive and ther--apeutic interventions that are currently lacking and which could save millions of newborn lives and reduce health care costs and morbidity and disability. However, to effectively contribute to the prevention of newborn mortality and morbidity, research should not be focused solely on the determinants of specific conditions responsible for large numbers of newborn deaths. Importantly, research is also needed to assess how to implement interventions within the health systems, especially those that would reach populations in most need. 16 Despite their limitations, our results do show that, even for babies who are born in hospitals with access to tertiary care, there could be room for improve--ment in newborn health outcomes that would close the equity gap between rich and poor countries in maternal and new--born health. O
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Nhu Thi Nguyen Ngoc et al. Resultados La tasa de mortinatalidad fue del 12,5 por 1000 nacimientos, y la tasa de mortalidad neonatal precoz, de 9,0 por 1000 nacidos vivos. El parto pretérmino espontáneo y los trastornos hipertensivos fueron los casos obstétricos más comunes asociados a las defunciones perinatales (28,7% y 23,6%, respectivamente). La prematuridad fue la causa principal de las defunciones neonatales precoces (62%). Conclusiones Los progresos de la atención a los lactantes prematuros y la prevención del parto pretérmino espontáneo y de los trastornos hipertensivos del embarazo podrían propiciar una disminución sustancial de la mortalidad perinatal en los entornos hospitalarios en los países en desarrollo. 
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